Fortress Biotech (NASDAQ: FBIO) reported Q3 EPS of ($0.94), $0.72 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $34.75 million versus the consensus estimate of $14.28 million.

For earnings history and earnings-related data on Fortress Biotech (FBIO) click here.